These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16953223)

  • 1. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
    Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
    Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
    Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and overexpression of E2F3 in human bladder cancer.
    Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
    Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
    Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
    Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
    Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
    J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
    Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
    Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
    Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
    Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of 6p22 genomic gain in retinoblastoma.
    Orlic M; Spencer CE; Wang L; Gallie BL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
    Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
    Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
    Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
    Shen H; Morrison CD; Zhang J; Underwood W; Yang N; Frangou C; Eng K; Head K; Bollag RJ; Kavuri SK; Rojiani AM; Li Y; Yan L; Hill A; Woloszynska-Read A; Wang J; Liu S; Trump DL; Candace JS
    Oncotarget; 2013 Nov; 4(11):2124-34. PubMed ID: 24231253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
    Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
    Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.
    Grasemann C; Gratias S; Stephan H; Schüler A; Schramm A; Klein-Hitpass L; Rieder H; Schneider S; Kappes F; Eggert A; Lohmann DR
    Oncogene; 2005 Sep; 24(42):6441-9. PubMed ID: 16007192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
    Kao J; Pollack JR
    Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
    Reimer D; Hubalek M; Kiefel H; Riedle S; Skvortsov S; Erdel M; Hofstetter G; Concin N; Fiegl H; Müller-Holzner E; Marth C; Altevogt P; Zeimet AG
    Oncogene; 2011 Sep; 30(38):4038-49. PubMed ID: 21516127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
    Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
    Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.